Rivastigmine

Back to search

Molecule Structure

Scientific Name

Rivastigmine

Description of the Drug

Rivastigmine is a cholinesterase inhibitor used to treat mild to moderate dementia in Alzheimer’s and Parkinson’s.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00989

Brand Name(s)

Alzest, Eluden, Erastig, Exelon, Kerstipon, Nimvastid, Prometax, Rivastigmine, Somniton, Voleze

Company Owner(s)

Apotex Inc, Alembic Pharmaceuticals Ltd, Amneal Pharmaceuticals Of New York Llc, Macleods Pharmaceuticals Ltd, Alvogen Inc, Watson Laboratories Inc, Sun Pharmaceutical Industries Ltd, Chartwell Rx Sciences Llc, Dr Reddys Laboratories Inc, Aurobindo Pharma Ltd

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Cholinesterases; ACHE & BCHE SELECTIVITY GROUP INHIBITOR CHEMBL2095233

Unichem Links

SureChEMBL SCHEMBL2764
PharmGKB PA451262
Human Metabolome Database HMDB0015124
DrugBank DB00989
PubChem: Thomson Pharma 15122215 14774320
PubChem 77991
LINCS LSM-5280
Nikkaji J982.502I
BindingDB 11682 10620
EPA CompTox Dashboard DTXSID7023564
DrugCentral 2392
Brenda 231326 117556
ChemicalBook CB92656938
Guide to Pharmacology 6602
rxnorm RIVASTIGMINE EXELON RIVASTIGMINE TARTRATE
KEGG Ligand C11766
ChEBI 8874
ZINC ZINC000000004413